4.7 Article

Proteomic profiling of a patient with cutaneous melanoma metastasis regression following topical contact sensitizer diphencyprone and immune checkpoint inhibitor treatment

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Nivolumab Plus Relatlimab: First Approval

Julia Paik

Summary: Nivolumab plus relatlimab is a combination immunotherapy treatment being developed for multiple types of advanced cancers. The treatment targets immune checkpoints using monoclonal antibodies. In March 2022, it received its first approval in the USA for unresectable or metastatic melanoma.
Review Immunology

TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy

Joseph G. Skeate et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

A decade of immune-checkpoint inhibitors in cancer therapy

Caroline Robert

NATURE COMMUNICATIONS (2020)

Review Immunology

Regulation of PD-L1 Expression by NF-κB in Cancer

Fabrizio Antonangeli et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Dermatology

Diphencyprone as a therapeutic option in cutaneous metastasis of melanoma. A single-institution experience

Ivana Lameiras Gibbons et al.

ANAIS BRASILEIROS DE DERMATOLOGIA (2018)

Review Biochemistry & Molecular Biology

Immune checkpoint inhibitors: recent progress and potential biomarkers

Pramod Darvin et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

Review Oncology

LAMPs: Shedding light on cancer biology

Federica Alessandrini et al.

SEMINARS IN ONCOLOGY (2017)

Article Multidisciplinary Sciences

Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions

Kirti V. Sawant et al.

SCIENTIFIC REPORTS (2016)

Review Pharmacology & Pharmacy

CD70: An emerging target in cancer immunotherapy

J. Jacobs et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Review Oncology

Nivolumab in NSCLC: latest evidence and clinical potential

Raghav Sundar et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2015)

Review Immunology

Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases

Alessandro Antonelli et al.

AUTOIMMUNITY REVIEWS (2014)

Review Oncology

Topical Immunotherapy with Diphencyprone for in Transit and Cutaneously Metastatic Melanoma

Diona L. Damian et al.

JOURNAL OF SURGICAL ONCOLOGY (2014)